Advertisement

Wiener Medizinische Wochenschrift

, Volume 157, Issue 19–20, pp 493–502 | Cite as

Pilzvergiftungen: Toxidrome, Diagnose und Therapie

  • Peter KaufmannEmail author
Themenschwerpunkt

Zusammenfassung

Pilzvergiftungen sind in der Regel nicht organschädigend, wenn Krankheitssymptome nach der Mahlzeit rasch, innerhalb von 6 Stunden auftreten. Mit einem isolierten Brechdurchfall ist bei der Mehrzahl dieser Intoxikationen zu rechnen und die Gabe von Medizinalkohle ist zur Verminderung der intestinalen Gift-resorption gerechtfertigt. Ein akutes Abdomen kann jedoch auch mit einer cholinergen Reaktion, einem epileptiformen Syndrom oder einer Immunhämolyse kombiniert sein. Die Therapie ist supportiv und konzentriert sich primär auf den Ersatz der gastrointestinalen Elektrolyt- und Flüssigkeitsverluste. Neurotoxische Syndrome inkludieren Rauschzustände, Halluzinationen und Alkoholunverträglichkeitsreaktionen. Die Behandlung ist symptomatisch und sollte ausnahmslos stationär erfolgen, bis die Symptome vollständig abgeklungen sind. Dann ist die Prognose gut. Treten Beschwerden nach einer längeren Latenzzeit als 6 Stunden auf, besteht Lebensgefahr infolge Leberund Nierenversagens. Nach Brechdurchfällen weist eine Gelbsucht auf Knollenblätterpilzvergiftung hin, während bei fehlendem Ikterus Nierenschmerzen, blutiger Urin, Harnflut oder Harnverhalten eine Intoxikation mit Haarschleierlingen wahrscheinlich machen. In beiden Fällen ist eine intensivmedizinische Behandlung unabdingbar.

Schlüsselwörter

Giftpilze Pilze Toxidrome Verdorbene Nahrungsmittel Amatoxine 

Mushroom poisonings: Syndromic diagnosis and treatment

Summary

The major syndromes of mushroom poisoning can be divided by presentation timing: Early syndromes (symptom onset < 6 hrs after ingestion) have little probability to cause organ damage. Epigastric pain, nausea, vomiting and diarrhea occur in most cases and treatment includes initial gastrointestinal decontamination with oral activated charcoal and fluid rehydration. In addition, an acute gastrointestinal syndrome can be combined with cholinergic toxicity, epileptiformic response or immunohemolytic anemia. Neurotoxic Syndromes may present as dysphoria, delirium, hallucinations or disulfiram-like reactions. Treatment is entirely supportive and if performed in hospital, the prognosis is good. Late syndromes (symptom onset > 6 hrs after ingestion) are life-threatening due to liver- and renal failure. Patients who are jaundiced after an acute gastrointestinal episode, are suspected to be poisoned with Amatoxins. Patiens with flank pain, hematuria, polyuria or oliguria in the absence of jaundice are suspected to have an intoxication with Cortinarius mushrooms. In both cases an intensive care management is indicated.

Keywords

Poisonous mushrooms Poisonous fungi Food poisoning Toxidrome Amatoxins 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Yilmaz A, Gursoy S, Varol O, Nur N, Ozyilkan E (2006) Emergency room cases of mushroom poisoning. Saudi Med J 27: 858–861PubMedGoogle Scholar
  2. Diaz JH (2005) Syndromic diagnosis and management of confirmed mushroom poisonings. Crit Care Med 33: 427–436PubMedCrossRefGoogle Scholar
  3. Benjamin DR (1992) Mushroom poisoning in infants and children: The Amanita pantherina/muscaria group. J Toxicol Clin Toxicol 30: 13–22PubMedGoogle Scholar
  4. Satora L, Pach D, Butryn B, Hydzik P, Balicka-Slusarczyk B (2005) Fly agaric (Amanita muscaria) poisoning, case report and review. Toxicon 45: 941–943PubMedCrossRefGoogle Scholar
  5. Brvar M, Mozina M, Bunc M (2006) Prolonged psychosis after amanita muscaria ingestion. Wien Klin Wochenschr 118: 294–297PubMedCrossRefGoogle Scholar
  6. Stijve T (1985) Occurence of psilocybin in various higher fungi from several European countries. Planta medica 5: 385–387CrossRefGoogle Scholar
  7. Franz M, Regele H, Kirchmair M, et al (1996) Magic mushrooms: Hope for a "cheap high" resulting in endstage renal failure. Nephrol Dial Transplant 11: 2324–2327PubMedGoogle Scholar
  8. Borowiak KS, Ciechanowski K, Waloscyzk P (1998) Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction. J Toxicol Clin Toxicol 36: 47–49PubMedCrossRefGoogle Scholar
  9. Goldfrank LR (2003) Mushrooms. In: Goldfrank LR, Flomenbaum NE, Lewin NA, et al (eds) Goldfrank's toxicologic emergencies. 7th edition. Appleton & Lange, Stamford, CT, pp 1115–1128Google Scholar
  10. Karlson-Stiber C, Persson H (2003) Cytotoxic fungi – An overview. Toxicon 42: 339–349PubMedCrossRefGoogle Scholar
  11. Michelot D, Toth B (1991) Gyromitra esculenta – A review. J Appl Toxicol 11: 235–243PubMedCrossRefGoogle Scholar
  12. Lampe KF (1979) Toxic fungi. Annu Rev Pharmacol Toxicol 19: 85–104PubMedCrossRefGoogle Scholar
  13. Breuer E, Stahler O (1966) Hämolytischer Ikterus bei Lorchelvergiftung. Med Welt 18: 1013–1016PubMedGoogle Scholar
  14. Hanrahan JP, Gordon MA (1984) Mushroom poisoning. JAMA 251(8 S): 1057–1061PubMedCrossRefGoogle Scholar
  15. Tottmar O, Lindberg P (1977) Effect on rat liver acetaldehyde dehydrogenase in vivo and in vitro by coprine, the disulfiram-like constituent of Coprinus atramentarius. Acta Pharmacol Toxicol 40: 476–481Google Scholar
  16. Carlson A, Henning B, Lindberg P et al (1978) On the disulfiram-like effect of coprine, the pharmacologically active priciple of Coprinus atramentarius. Acta Pharmacol Toxicol 42: 292–297CrossRefGoogle Scholar
  17. Marchner H, Tottmar O, Astenklyft PH et al (1978) A comparative study of disulfiram, cyanamide, and 1-aminocyclopropanol on the acetaldehyde metabolism in rats. Acta Pharmacol Toxicol 43: 219–232CrossRefGoogle Scholar
  18. Bschorr F, Mallach HJ (1963) Vergiftungen durch den Kahlen Krempling, eine genießbare Pilzart. Arch Toxicol 20: 82–95CrossRefGoogle Scholar
  19. Winkelmann M, Stangel W, Schedel I et al (1986) Severe hemolysis caused by antibodies against the mushroom paxillus involutus and its therapy by plasma exchange. J Mol Med 64(19): 935–938Google Scholar
  20. Flammer R (1985) Paxillus syndrome: Immunohemolysis following repeated mushroom ingestion. Schweiz Rundsch Med Prax 74: 997–999PubMedGoogle Scholar
  21. Lefévre H (1982) Immunhämolytische Anämie nach Genuß des Kahlen Krempling (Paxillus involutus). Dtsch Med Wochenschr 107: 1374Google Scholar
  22. Schmidt J, Hartmann W, Würstlin A, Deicher H (1971) Akutes Nierenversagen durch immunhämolytische Anämie nach Genuß des Kahlen Kremplings (Paxillus involutus). Dtsch Med Wochenschr 96: 1188PubMedCrossRefGoogle Scholar
  23. Winkelmann M, et al (1982) Tödlich verlaufende immunhämolytische Anämie nach Genuß des kahlen Kremplings. Dtsch Med Wochenschr 107: 1190–1194PubMedCrossRefGoogle Scholar
  24. Wieland TH, Faulstich H (1978) Amatoxins, phallotoxins, phallolysin and antamanide: The biologically active components of poisonous Amanita mushrooms. Crit Rev Biochem Mol Biol 5: 182–260Google Scholar
  25. Lindell TJ, Weinberg F, Morris PW et al (1970) Specific inhibition of nuclear RNA polymerase II by alpha-amanitin. Science 170: 447–449PubMedCrossRefGoogle Scholar
  26. Jaeger A, Jehl F, Flesch F et al (1993) Kinetics of amatoxins in human poisoning: Therapeutic implications. J Toxicol Clin Toxicol 31: 63–80PubMedGoogle Scholar
  27. Loranger A, Tuchweber B, Gicquaud C, St-Pierre S, Côté G (1985) Toxicity of peptides of amanita virosa mushrooms in mice. Toxicol Sci 5: 1144–1152CrossRefGoogle Scholar
  28. Schneider SM, Vanscoy G, Michelson EA (1991) Failure of cimetidine to affect phalloidin toxicity. Vet Hum Toxicol 33: 17–18PubMedGoogle Scholar
  29. Becker CE, Tong TG, Boerner U (1976) Diagnosis and treatment of Amanita phalloides-type mushroom poisoning: Use of thioctic acid. West J Med 125: 100–109PubMedGoogle Scholar
  30. Floersheim GL, Bianchi L (1984) Ethanol diminishes the toxicity of the mushroom Amanita phalloides. Experentia 40: 1268–1270CrossRefGoogle Scholar
  31. Yamada EG, Mohle Boetani J, Olson KR, et al (1998) Mushroom poisoning due to amatoxin: Northern California, winter 1996–1997. West J Med 169: 380–384PubMedGoogle Scholar
  32. Forro M, Mandli T (2003) Liver transplantation after amanita phalloides poisoning from the viewpoint of anaesthesia and intensive care of three cases. Orvosi Hetilap 144: 269–273PubMedGoogle Scholar
  33. Floersheim GL (1987) Treatment of human amatocin mushroom poisoning. Med Toxicol 2: 1–4PubMedGoogle Scholar
  34. Escudie L, Francoz C, Vinel JP, Moucari R, Cournot M, Paradis V, Sauvanet A, Belghiti J, Valla D, Bernuau J, Durand F (2006) Amanita phalloides poisoning: Reassessment of prognostic factors and indications for emergency liver transplantation. J Hepatol 46(3): 466–473PubMedCrossRefGoogle Scholar
  35. Wieland Th (1978) Zeitungspapiertest für Giftpilze. Umsch wiss Techn 78: 611–612Google Scholar
  36. Faulstich H, Zobely S, Trischmann H (1982) A rapid radioimmunoassay using a nylon support for amatoxin's from amanita mushrooms. Toxicon 20: 913–915PubMedCrossRefGoogle Scholar
  37. Vogel G, Tuchweber B, Trost W et al (1984) Protection by silibinin against Amanita phalloides poisoning in beagels. Toxicol Appl Pharmacol 73: 355–362PubMedCrossRefGoogle Scholar
  38. Enjalbert F, Rapior S, Noguier-Solué J et al (2002) Treatment of amatoxin poisoning: 20-year retrospective analysis. Toxicol Clin Toxicol 40: 715–757CrossRefGoogle Scholar
  39. Montanini S, Sinardi D, Practico C, et al (1999) Use of acetylcysteine as the life-saving antidote in amanita phalloides (death cap) poisoning. Case report on 11 patients. Arzneimittel Forschung 49: 1044–1047PubMedGoogle Scholar
  40. Schneider SM, Michelson EA, Vanscoy G (1992) Failure of N-acetylcysteine to reduce alpha amanitin toxicity. J Appl Toxicol 12: 141–142PubMedCrossRefGoogle Scholar
  41. Floersheim GL, Schneeberger J, Bucher K (1971) Curative potencies of penicillin in experimental Amanita phalloides poisoning. Agents & Actions 2: 138–141CrossRefGoogle Scholar
  42. Mullins ME, Horowitz BZ (2000) The futility of hemoperfusion and hemodialysis in amanita phalloides poisoning. Vet Hum Toxicol 42: 90–91PubMedGoogle Scholar
  43. Vesconi S, Langer M, Ipichino G et al (1985) Therapy of cytotoxic mushroom intoxication. Crit Care Med 13: 402–406PubMedCrossRefGoogle Scholar
  44. Piqueras J, Duran-Suarez JR, Massnet L et al (1987) Mushroom poisoning: Therapeutic apheresis or forced diuresis. Transfusion 27: 116–117PubMedCrossRefGoogle Scholar
  45. Sieberth HG (1982) Apparative Detoxifikation. Plasmaseparation. Intensivmedizin 19: 74–76Google Scholar
  46. Faybik P, Hetz H, Baker A, Bittermann C, Berlakovich G, Werba A, Krenn CG, Steltzer H (2003) Extracorporal albumin dialysis in patients with amanita phalloides poisoning. Liver Intern 23: 28–33CrossRefGoogle Scholar
  47. Rubik J, Pietraszek-Jezierska E, Kaminski A, et al (2004) Successful treatment of a child with fulminant liver failure and coma caused by amanita phalloides intoxication with albumin dialysis without liver transplantation. Pediatr Transplant 8: 295PubMedCrossRefGoogle Scholar
  48. Sein-Anand J, Chodorowski Z, Hydzik P (2005) Molecular adsorbent recirculating system – MARS as a bridge to liver transplantation in amanita phalloides intoxication. Przegl Lek 62: 480–481PubMedGoogle Scholar
  49. Panaro F, Andorno E, Morelli N, Casaccia M, Bottino G, Ravazzoni F, Centanaro M, Ornis S, Valente U (2006) Liver transplantation represents the optimal treatment for fulminant hepatic failure from amanita phalloides poisoning. Transplant International 19(4): 344–345PubMedCrossRefGoogle Scholar
  50. Flammer R (1982) Das Orellanus-Syndrom: Pilzvergiftung mit Niereninsuffizienz. Schweiz Med Wochenschr 112: 1181–1184PubMedGoogle Scholar
  51. Danel VC, Saviuc PF, Garon D (2001) Main features of Cortinarius spp. poisoning: A literature review. Toxicon 39: 1053–1060PubMedCrossRefGoogle Scholar
  52. Grzymala S (1957) Massenvergiftungen durch den orangefuchsigen Hautkopf. Z Pilzkd 23: 139–142Google Scholar
  53. Schumacher T, Hoiland K (1983) Mushroom poisoning caused by species of the genus cortinarius fries. Arch Toxicol 53: 87–106PubMedGoogle Scholar
  54. Bouget J, Bousser J, Pats B et al (1990) Acute renal failure following collective intoxication by Cortinarius orellanus. Intensive Care Med 16: 506–515PubMedCrossRefGoogle Scholar
  55. Horn S, Horina JH, Krejs GJ, Holzer H, Ratschek M (1997) Endstage renal failure from mushroom poisoning with Cortinarius orellanus: report of four cases and review of the literature. Am J Kidney Diseases 30(2): 282–286Google Scholar
  56. Holmdahl J, Blohmé I (1995) Renal transplantation after Cortinarius speciosissimus poisoning. Nephrol Dial Transplant 10: 1920–1922PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2007

Authors and Affiliations

  1. 1.Universitätsklinik für Innere MedizinMedizinische Universität GrazGrazAustria

Personalised recommendations